07.01.09
According to a multi-center, randomized, double-blind, placebo-controlled trial, geniVida, a proprietary form of pure genistein from DSM Nutritional Products, reduces the number and duration of hot flashes in peri- and postmenopausal women.
Women receiving 30 mg per day of geniVida experienced 40% fewer hot flashes after 8 weeks and 44% fewer hot flashes after 12 weeks. Furthermore, 88.5% of women in the geniVida group had a 25% or greater reduction in the duration of daily hot flashes after 12 weeks. There were no differences between the groups for any of the safety factors or adverse events. The study was conducted by KGK Synergize and sponsored by DSM. For further information: www.dsm.com
Women receiving 30 mg per day of geniVida experienced 40% fewer hot flashes after 8 weeks and 44% fewer hot flashes after 12 weeks. Furthermore, 88.5% of women in the geniVida group had a 25% or greater reduction in the duration of daily hot flashes after 12 weeks. There were no differences between the groups for any of the safety factors or adverse events. The study was conducted by KGK Synergize and sponsored by DSM. For further information: www.dsm.com